Sector portfolio · VC firm · United States

Kleiner Perkins Caufield & Byers' Biotech portfolio

Kleiner Perkins Caufield & Byers has backed 26 Biotech startups in rounds we track, $2.7B between them, shown by the stage each has reached. The best-funded is Epizyme.

26startups backed
5stages
$2.7Braised between them
Stage not reportedbiggest stage

Kleiner Perkins Caufield & Byers's whole portfolioKleiner Perkins Caufield & Byers's profile

Segment by segment

Stage not reported

11 startups · $1.2B raised

  1. EpizymeEpizyme is a biopharmaceutical company focusing on treatments for blood cancer and tumors.United States$332M
  2. CelladonCelladon is a biotechnology company developing molecular therapies for the treatment of heart failure.United States$172M
  3. True North TherapeuticsTrue North Therapeutics is a pioneering biotechnology company selectively inhibiting the Complement pathway for diseases.United States$142M
  4. NeuroPaceNeuroPace develops and markets implantable devices for the treatment of neurological disorders.United States$141M
  5. EdeniQEdeniq is a leading biotechnology company that develops processes for producing and measuring cellulosic ethanol from corn kernel fiber.United States$119M
  6. ABARMO BioSciencesARMO Biosciences is a biotechnology company that develops immune modulatory biologic therapeutics.United States$117M
  7. NNunaUnited States$90M
  8. Flexus BiosciencesFlexus Biosciences is a biotechnology company based in San Carlos, California, founded in 2013.United States$53M

Series C and later

6 startups · $741M raised

  1. ZLZai LabChina$310M
  2. 3B3-V BiosciencesUnited States$146M
  3. Elcelyx TherapeuticsElcelyx Therapeutics is developing nutrient sensing-based products for weight management and obesity-related metabolic disorders.United States$117M
  4. RenmatixRenmatix is a plant ingredient innovation company that specializes in converting biomass into sustainable materials using its propUnited States$89M
  5. KCKit CheckUnited States$48M
  6. XcellerexXcellerex is a supplier of manufacturing technologies, developing and producing biomanufacturing systems and production-scale bioreactors.United States$31M

Series B

4 startups · $234M raised

  1. NoomNoom is a prominent digital health company based in New York City, founded in 2008 by Saeju Jeong and Artem Petakov.United States$86M
  2. Atara BiotherapeuticsAtara Biotherapeutics (Nasdaq: ATRA) is an off-the-shelf, allogeneic T-cell immunotherapy company.United States$69M
  3. JBJuvaris BioTherapeuticsJuvaris BioTherapeutics develops adjuvanted vaccines and immunotherapeutics to treat cancer and infectious diseases.United States$55M
  4. PProgynyUnited States$25M

Growth

3 startups · $444M raised

  1. LHLivongo HealthUnited States$188M
  2. FPFive Prime TherapeuticsFivePrime is a clinical-stage biotechnology company that develops treatments for cancers.United States$146M
  3. AAccumetricsAccumetrics develops, manufactures, and markets the VerifyNow System, a suite of assays for the assessment of platelet functionUnited States$111M

Series A

2 startups · $75M raised

  1. EExpansionUnited States$55M
  2. iZumi BioIZumi Bio, a biotechnology company, employs cellular reprograming for the development of stem cell-based therapeutics.United States$20M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Kleiner Perkins Caufield & Byers as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios

Raising from investors like Kleiner Perkins Caufield & Byers?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.